IFN-alpha 2 Antibody (995510) [CoraFluor™ 1]
Novus Biologicals, part of Bio-Techne | Catalog # FAB93455CL1

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry
Label
CoraFluor 1
Antibody Source
Monoclonal Mouse IgG1 Clone # 995510
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
HEK293 human embryonic kidney cell line transfected with human IFN‑ alpha2/IFNA2
Met1-Glu188
Accession # P01563
Met1-Glu188
Accession # P01563
Specificity
Detects human IFN‑ alpha2/IFNA2 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for IFN-alpha 2 Antibody (995510) [CoraFluor™ 1]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark. Do not freeze.
Background: IFN-alpha 2/IFNA2
Long Name
Interferon alpha 2
Alternate Names
Ifa2, IFNA2, IFNA2a, IFNA2b, IFNA2c, IFNAA, IFNalpha 2
Additional IFN-alpha 2/IFNA2 Products
Product Documents for IFN-alpha 2 Antibody (995510) [CoraFluor™ 1]
Product Specific Notices for IFN-alpha 2 Antibody (995510) [CoraFluor™ 1]
CoraFluor (TM) is a trademark of Bio-Techne Corp. Sold for research purposes only under agreement from Massachusetts General Hospital. US patent 2022/0025254
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...